(Unaudited)
| Nine Months Ended September 30, | ||||||||
| (In thousands) | 2021 | 2020 | ||||||
| OPERATING ACTIVITIES: | ||||||||
| Net loss | $ | (7,397 | ) | $ | (12,698 | ) | ||
| Adjustments to reconcile net loss to net cash provided by operating activities: | ||||||||
| Depreciation and amortization | 19,355 | 16,916 | ||||||
| Provision for credit loss | 330 | 930 | ||||||
| Amortization of debt discount and issuance costs | 8,513 | 8,067 | ||||||
| Stock-based compensation expense | 31,229 | 13,939 | ||||||
| Deferred income taxes | (510 | ) | (5,441 | ) | ||||
| Other, net | 40 | 13 | ||||||
| Changes in assets and liabilities: | ||||||||
| Accounts receivable | 26,770 | 16,213 | ||||||
| Prepaid expenses and other current assets | (7,612 | ) | (1,055 | ) | ||||
| Other long-term assets | (5,018 | ) | 867 | |||||
| Accounts payable | (2,432 | ) | (3,321 | ) | ||||
| Accrued compensation and benefits | 481 | 1,274 | ||||||
| Other accrued expenses and current liabilities | 483 | (5,873 | ) | |||||
| Deferred revenue | (8,638 | ) | (2,452 | ) | ||||
| Net cash provided by operating activities | 55,594 | 27,379 | ||||||
| INVESTING ACTIVITIES: | ||||||||
| Capital expenditures | (6,811 | ) | (4,006 | ) | ||||
| Payments for acquisition of businesses, net of cash acquired | (5,472 | ) | (32,279 | ) | ||||
| Payments for acquisition of developed technology | (344 | ) | (433 | ) | ||||
| Other investing activities, net | (284 | ) | 152 | |||||
| Net cash used in investing activities | (12,911 | ) | (36,566 | ) | ||||
| FINANCING ACTIVITIES: | ||||||||
| Proceeds from private placement of common stock | 200,000 | — | ||||||
| Payments on revolving commitment | (30,000 | ) | — | |||||
| Proceeds from employee stock purchase plan contributions | 2,110 | — | ||||||
| Proceeds from the exercise of common stock options | 2,059 | 1,094 | ||||||
| Borrowings under revolving commitment | — | 30,000 | ||||||
| Other financing activities | (434 | ) | (401 | ) | ||||
| Net cash provided by financing activities | 173,735 | 30,693 | ||||||
| Effect of exchange rate changes on cash, cash equivalents and restricted cash | (1,951 | ) | 676 | |||||
| Net increase in cash, cash equivalents and restricted cash | 214,467 | 22,182 | ||||||
| Cash, cash equivalents and restricted cash at beginning of year | 241,547 | 223,497 | ||||||
| Cash, cash equivalents and restricted cash at end of period | $ | 456,014 | $ | 245,679 | ||||
| Supplemental disclosure of cash flow: | ||||||||
| Interest paid | $ | 344 | $ | 320 | ||||
| Income taxes paid | $ | 8,077 | $ | 12,142 | ||||
| Supplemental disclosure of non-cash investing and financing activities: | ||||||||
| Finance leases | $ | — | $ | 117 | ||||
| Property and equipment in accounts payable, other current liabilities
and other liabilities | $ | 480 | $ | 208 | ||||
